Krystal Biotech, Inc. KRYS Operating Lease Liability - Undiscounted Excess Amount
Operating Lease Liability - Undiscounted Excess Amount at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s operating lease liability - undiscounted excess amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s operating lease liability - undiscounted excess amount?
- Krystal Biotech, Inc. (KRYS) reported operating lease liability - undiscounted excess amount of $7.46M in Q1 2026.
- How has Krystal Biotech, Inc.'s operating lease liability - undiscounted excess amount changed year-over-year?
- Krystal Biotech, Inc.'s operating lease liability - undiscounted excess amount decreased by 11.6% year-over-year, from $8.44M to $7.46M.